Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis.
Cara E MorinReem HaswehChris AntonJonathan R DillmanEmily OrschelnEthan A SmithMeera KotagalBrian D WeissJiarong OuyangBin ZhangAndrew T TroutAlexander J TowbinPublished in: Pediatric blood & cancer (2023)
Contrast does not improve tumor size measurement or radiologist agreement on the presence or absence of IDRFs or metastatic disease in children with newly diagnosed neuroblastoma.